Mark W. Adams was appointed to the Board of Core Scientific, Inc. on July 29, 2026. Most recently, he served as President and Chief Executive Officer of Penguin Solutions, Inc., a provider of memory and AI infrastructure, from August 2020 through January 2026. Prior to that, he was Chief Executive Officer of Lumileds, Inc., a global leader in LED and OEM lighting solutions, from February 2017 to March 2019.
Adams spent the majority of his career at Micron Technology, where he served as President from 2012 to 2016 and held various leadership roles from 2006 through February 2012. He brings over 25 years of experience in the technology sector, including semiconductors and memory solutions.
Adams currently serves as a director of Seagate Technology Holdings Public Limited Company and Cadence Design Systems, Inc. The Core Scientific Board determined him to be independent under Sarbanes-Oxley and Nasdaq listing standards.
Biography extracted from Core Scientific 8-K filed 2026-07-29 View cached copy (2026-08-30)Live source ↗
Roles
Contiguous filings for the same role are collapsed into a single tenure span. Click a row to see the underlying filings.
| Company | Role | Tenure | Filings |
|---|---|---|---|
| Core Scientific | Director | 2026-07 → present (2mo) | 2 |
Show 2 underlying filings | |||
Insider transactions
Totals for this person
| Bucket | Invested (shares) | Invested (USD) | Divested (shares) | Divested (USD) | Net direction | Txns | Invested @ last price | Divested @ last price |
|---|---|---|---|---|---|---|---|---|
| All time | 27,594 | $0 | - | $0 | Flat | 1 | $493.7K | $0 |
| 2026 | 27,594 | $0 | - | $0 | Flat | 1 | $493.7K | $0 |
| 2026-Q3 | 27,594 | $0 | - | $0 | Flat | 1 | $493.7K | $0 |
Invested = shares acquired (buys, grants, option exercises) — insider adding to the position. Divested = shares reduced (sells, dispositions, tax-withholding) — cash flowing TO the insider. Net direction shows which side wins on dollar terms in each bucket. % of holder's stake not yet computed (pending Form 3/4 holdings ingest). See methodology. The two @ last price columns restate the same share counts at the most recent share price we read (close of 2026-09-04); they are a valuation, not a cash flow, and they move every day the market does.
All transactions
| Date | Company | Kind | Shares | Amount (USD) | Value @ last price |
|---|---|---|---|---|---|
| 2026-07-30 | Core Scientific | Grant / award / vesting | 27,594 | - | $493.7K |